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Abstract: Ibuprofen, a non-steroidal anti-inflammatory pain reliever, is among pharmaceutical
residues of environmental concern ubiquitously detected in wastewater effluents and receiving rivers.
Thus, ibuprofen removal potentials and associated bacteria in the hyporheic zone sediments of an
impacted river were investigated. Microbially mediated ibuprofen degradation was determined in
oxic sediment microcosms amended with ibuprofen (5, 40, 200, and 400 µM), or ibuprofen and acetate,
relative to an un-amended control. Ibuprofen was removed by the original sediment microbial
community as well as in ibuprofen-enrichments obtained by re-feeding of ibuprofen. Here, 1-,
2-, 3-hydroxy- and carboxy-ibuprofen were the primary transformation products. Quantitative
real-time PCR analysis revealed a significantly higher 16S rRNA abundance in ibuprofen-amended
relative to un-amended incubations. Time-resolved microbial community dynamics evaluated
by 16S rRNA gene and 16S rRNA analyses revealed many new ibuprofen responsive taxa of the
Acidobacteria, Actinobacteria, Bacteroidetes, Gemmatimonadetes, Latescibacteria, and Proteobacteria.
Two ibuprofen-degrading strains belonging to the genera Novosphingobium and Pseudomonas were
isolated from the ibuprofen-enriched sediments, consuming 400 and 300 µM ibuprofen within three
and eight days, respectively. The collective results indicated that the hyporheic zone sediments
sustain an efficient biotic (micro-)pollutant degradation potential, and hitherto unknown microbial
diversity associated with such (micro)pollutant removal.
Keywords: ibuprofen; hyporheic zone; sediments; micropollutant; biodegradation; model organism;
microbial ecology
1. Introduction
Ibuprofen is a non-steroidal anti-inflammatory drug widely consumed globally for its analgesic,
anti-inflammatory, and antipyretic properties. Its removal in most wastewater treatment plants
(WWTPs) is relatively efficient (about 90%) [1]. However, low to trace concentrations of the
pharmaceutical continue to be detected in the aquatic environment. This may be attributed to
the continuous input of the compound via raw sewage coupled with a short retention time in the
WWTPs, resulting in pseudo-persistence [2]. Toxic effects of ibuprofen in the environment have been
documented. For example, ibuprofen alongside other pharmaceutical residues reduced the bacterial
biomass of some riverine biofilm communities [3]. Cytotoxic effects of ibuprofen combined with other
pharmaceuticals on human kidney embryonic cells have also been reported [4]. Ibuprofen was detected
in the bile of wild fish caught downstream of a WWTP [5] in addition to the adverse impact on the
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reproduction of some aquatic organisms, such as zebrafish, planktonic crustaceans, and the Japanese
rice fish [6]. Such findings give rise to concerns on the long-term ecological impact of the compound
on aquatic ecosystems.
Ibuprofen-containing effluents are usually part of the surface water volume exchanged between
the open channel and the permeable streambed sediments (hyporheic zone) of impacted rivers.
These hyporheic zones are thought to play a critical role in the cycling of nutrients and degradation of
pollutants as they are characterized by the active exchange of pore water, nutrients, and biota between
surface water and aquifers [7]. The large surface area occupied by sediment particles, pore spaces,
organic matter, and the prevalence of redox gradients along the sediment profile represent an ideal
habitat for the proliferation of a diverse microbial community with high metabolic versatility [8].
Though biodegradation is considered the primary attenuation mechanism for ibuprofen in both
constructed and natural environments, the bacteria associated with this degradation in the streambed
sediments are virtually unknown [9–12].
To date, only several bacterial strains, Bacillus thuringiensis B1 (2015b), Sphingomonas Ibu-2,
Variovorax Ibu-1, Sphingobium yanoikuyae, and Pseudoxanthomonas sp. DIN-3, have been shown to utilize
ibuprofen as the sole source of carbon and energy, with oxygen as the terminal electron acceptor [13–17].
Transformation products, such as ibuprofen carboxylic acid (CBX IBU), 2-hydroxyibuprofen (2-OH
IBU), 1-hydroxyibuprofen (1-OH IBU), and 1,2-dihydroxy ibuprofen detected in batch experiments with
activated sludge, biofilm reactors, and Bacillus thuringiensis B1 [9,15,18], suggest diverse biodegradation
pathways, likely driven by diverse microbial communities. In the sediment, a high diversity of the
resident bacterial community and a rather long contact time in the sediment matrix [19–21] suggest an
ideal microhabitat with an enhanced ibuprofen biodegradation potential relative to WWTPs.
The projected population growth and rapid urbanization will likely result in increased consumption
of ibuprofen and associated release into the aquatic ecosystems. Such contamination of receiving
rivers that are a significant source of drinking water globally may result in dire consequences to
human and overall ecosystem wellbeing. Understanding the impact of ibuprofen on the indigenous
microbial community composition and diversity would contribute to understanding the dynamics
regulating ibuprofen removal in the hyporheic zone. However, the current knowledge of ibuprofen
degradation-associated genes or metabolic pathways is limited. Thus, functional gene-based approaches
are inadequate to date in order to target ibuprofen degraders, and new model organisms for their
development are warranted. Identification of ibuprofen-responsive taxa based on analysis of their
16S rRNA gene, and isolation is a promising strategy to identify hitherto unknown candidates for key
bacterial taxa with ibuprofen degradation capabilities.
Based on the information and knowledge gaps highlighted, we hypothesize that hyporheic zone
sediments are a reservoir of diverse hitherto unknown microbes that are prone to quickly respond to
ibuprofen, thus sustaining a high ibuprofen degradation potential. Our objectives were to (i) determine
ibuprofen biodegradation potentials in the hyporheic zone sediment downstream from a WWTP using
oxic microcosm incubations, (ii) identify degradation intermediates and hypothetical degradation
pathways, (iii) relate microbial community changes to ibuprofen exposure, and hence to (iv) identify
potential ibuprofen degraders, including the provision of new model ibuprofen degraders.
2. Materials and Methods
2.1. Study Site and Sampling
The River Erpe is a lowland stream located east of Berlin, Germany. It is a receiving river, highly
impacted by the municipal wastewater from the WWTP Münchehofe that accounts for 60–80% of
its total discharge. The sampling site is located approximately 0.7 km downstream of the effluent
discharge site at Heidemühle (latitude, 52.478647; longitude, 13.635146). The site is characterized
by fine-sandy siliceous sediment as determined in a previous field study [19]. Sediment and water
samples were collected from the site in September 2015. Surface sediment samples (0–5 cm depth) were
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collected from several spots on the streambed with a flat hand shovel and stored in sterile Whirl-Pak
sampling bags (Merck, Darmstadt, Germany). Surface water samples were obtained from the same site
and stored in sterile 2-L screw-mouth Duran® bottles (Merck, Darmstadt, Germany). Freshly collected
sediment and water samples were transferred to the laboratory at 4 ◦C, manually homogenized, and an
aliquot stored at −80 ◦C for subsequent nucleic acid extraction. The remaining fresh sediment was
stored at 4 ◦C and used to set up microcosm incubation experiments within two weeks.
2.2. Chemicals
Analytical-grade ibuprofen, 1-, 2-, 3-hydroxyibuprofen, carboxy-ibuprofen, and sodium acetate
trihydrate were purchased from Sigma-Aldrich (Steinheim, Germany). HPLC-grade acetonitrile and
H2SO4 was purchased from Merck (Darmstadt, Germany). Isotopically labelled internal standards
(purity >98%), were purchased from Toronto Research Chemicals Inc. (North York, ON, Canada).
Stock solutions of ibuprofen (1 mM) and 10 mM acetate were prepared separately in distilled water
and filter sterilized (0.2 µm pore diameter), whereas internal standards were prepared in methanol.
2.3. Microcosm Setup
The microcosms were prepared in triplicates using 25 g of fresh sediment and 50 mL of natural
river water in autoclaved 120-mL conical flasks. A 10-day oxic pre-incubation at 15 ◦C to reduce
endogenous dissolved organic carbon was performed. Subsequently, one set of microcosms was
amended with ibuprofen to achieve final concentrations of 5, 40, 200, and 400 µM. The second set
was amended with the same ibuprofen concentrations and 1 mM acetate to test for the cometabolic
degradation potential of ibuprofen. An unamended control setup consisting of microcosms without
ibuprofen and acetate and two abiotic controls comprising of autoclave-sterilized sediment (i.e.,
sorption control), and autoclave-sterilized river water (i.e., hydrolysis control) amended with a final
concentration of 200 µM ibuprofen were included. All flasks were sealed with sterilized Steristoppers®
(Heinz Herenz, Hamburg, Germany). Oxic microcosms were then incubated in the dark at 15 ◦C with
shaking at 100 rotations per minute. Liquid samples were taken under sterile conditions after the first
amendment (t0) and at regular intervals following incubation and the concentration of ibuprofen and
acetate determined using the high-performance liquid chromatography (HPLC) (see below). Ibuprofen
or ibuprofen-acetate were refed four more times to the same initial concentrations upon complete
substrate depletion (i.e., five amendments in total). Following the third refeeding and at the end of the
incubation (after the fifth refeeding), 2 g of sediment subsamples were taken from the treatments and
the unamended controls and stored at −80◦C for subsequent nucleic acid extraction.
2.4. Chemical Analyses
The concentration of test compounds was determined from centrifuged slurry samples (13,000× g,
5 min). The supernatant was microfiltered (0.22 µm pore diameter, PTFE membrane) and quantification
performed with HPLC. Ibuprofen was quantified using an Agilent 1260 series HPLC fitted with a
Zorbax SB-C18 column at 30 ◦C and a diode array detector (Agilent 1260 series, Agilent Technologies,
Santa Clara, CA, USA) under isocratic conditions. The mobile phase was acetonitrile-20 mM acetate
buffer (50:50 v/v), pH 3 at a flow rate of 0.5 mL min-1. Spectra ranging from 200 to 320 nm were used to
determine peak purity. The absorbance signal at 225 nm was used for quantification with external
standards prepared in deionized water.
Aliquots of the samples obtained from the 200µM ibuprofen treatment after the fifth refeeding were
analyzed for ibuprofen transformation intermediates using a newly developed and validated direct
injection method utilizing ultra-high-performance liquid chromatography-tandem mass spectrometry
(UHPLC-MS/MS; [22]). Briefly, separations were carried out on a Thermo Scientific (Waltham, MA,
USA) Dionex Ultimate 3000 UHPLC system equipped with a Waters (Manchester, UK) ACQUITY
UPLC HSS T3 column (1.8 µm, 2.1 mm × 100 mm). A mobile phase gradient of 97% deionized water
(+10 mM acetic acid, A) and 97% methanol (+10 mM acetic acid, B) was used. The mobile phase
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gradient was ramped from 97% A to 97% B in 16 min to achieve separation of 2-OH ibuprofen and
3-OH ibuprofen. For MS/MS analysis, a Thermo Scientific Quantiva triple-stage quadrupole mass
spectrometer with an H-ESI interface was operated in negative selected reaction monitoring mode.
MS data were processed using ‘Xcalibur 3.1.66.10′ (Thermo Scientific, Waltham, MA, USA). Precision
was excellent for all compounds with <5% relative standard deviation of a quality control standard
measured every 10 samples.
The acetate concentration was measured using HPLC (1090 series II, Hewlett Packard, Palo Alto,
USA) equipped with a variable wavelength UV detector (Series 1200, Agilent Technologies, Böblingen,
Germany) at an absorption wavelength of 210 nm. Liquid samples (10 µL) were injected into the
mobile phase (4 mM H3PO4, pH 2.5) via an autosampler and the sample-mobile phase mixture was
pumped through an ion exclusion column (Rezex ROA Organic Acid H+ column, 300 × 7.8 mm,
Phenomenex, Torrance, CA, USA) with a flow rate of 0.8 mL min−1. The column was heated to 60 ◦C.
The concentration was calculated based on the peak area from known concentrations of six to eight
external standards.
2.5. Nucleic Acids Extraction, Quantification, and Reverse Transcription
Nucleic acids were extracted from each of the three independent replicates per treatment following
a published protocol [23]. DNA and RNA were obtained from the coextracts using DNase-free RNase
and RNase-free DNase (Promega, Mannheim, Germany), respectively, following the manufacturer’s
instructions. RNA samples were confirmed to be DNA free after a control PCR targeting the 16S
rRNA gene (primers 27F and 907R; [24] according to [25]), showing no amplification. DNA and RNA
concentrations were determined with Quant-iT® PicoGreen DNA and RiboGreen RNA assay kits
(Invitrogen, Karlsruhe, Germany), respectively, on a Multiskan™ FC Microplate Photometer (Thermo
Fischer Scientific, Darmstadt, Germany). Reverse transcription of RNA into complementary DNA
(cDNA) was performed using random hexamer primers and Superscript™ III Reverse Transcriptase
(Invitrogen, Karlsruhe, Germany) following [26].
2.6. Amplicon Sequencing
Amplification and sequencing of the bacterial 16S rRNA genes and 16S rRNA were performed at
LGC Genomics GmbH (Berlin, Germany). Briefly, the PCR consisted of 1 ×MyTaq buffer containing
1.5 units MyTaq DNA polymerase (Bioline, UK) and 2 µL of BioStabII PCR Enhancer (Sigma-Aldrich,
Darmstadt, Germany), 15 pmol of each forward primer U341F and reverse primer U806R [27], and 5 ng
of DNA/cDNA per sample in nuclease-free water (Thermo Fischer Scientific, Darmstadt, Germany) in
a final 20-µL volume (protocol kindly provided by LGC). For each sample, the forward and reverse
primers had the same 10-nt barcode sequence. The PCR was carried out using the following thermal
profile: 2 min at 96 ◦C initial denaturation followed by 30 cycles of 96 ◦C for 15 s, 50 ◦C for 30 s,
and elongation at 70 ◦C for 90 s. Amplification was confirmed by gel electrophoresis on 1% agarose gels.
About 20 ng of amplicon DNA of each sample were pooled for up to 48 samples with different barcodes.
If needed, PCRs showing low yields were further amplified for five cycles. The amplicon pools were
purified with one volume AMPure XP beads (Beckman Coulter, Brea, CA, USA), to remove primer
dimers, followed by an additional purification on MinElute columns (Qiagen, Hilden, Germany).
About 100 ng of each purified amplicon pool DNA were used to construct Illumina sequencing libraries
using the Ovation Rapid DR Multiplex System 1-96 (NuGEN, Leek, The Netherlands). Illumina libraries
were pooled, and the size selected by preparative gel electrophoresis. Sequencing was performed on
an Illumina MiSeq platform using V3 Chemistry (Illumina, San Diego, CA, USA) yielding 300-base
paired-end reads.
Processing of Amplicon Sequence Data
Raw 16S rRNA gene and 16S rRNA sequences were pre-processed by demultiplexing all libraries
using the Illumina bcl2fastq 1.8.4 software. The reads were then sorted by amplicon inline barcodes
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corresponding to independent samples. The barcode sequences were clipped from sequences after
sorting, followed by clipping of the sequencing adapter remnants from all reads. Reads with a
final length <100 bases were discarded. Primer sequences were removed, the sequence fragments
turned into forward-reverse orientation, and merged using BBMerge 34.38. 16S pre-processing and
operational taxonomic unit (OTU) picking from amplicons was performed with Mothur 1.35.1 [28].
Briefly, sequences containing ambiguous bases (Ns), with homopolymer stretches of more than eight
bases or with an average Phred quality score below 33 were removed. Remaining sequences were
aligned against the 16S Mothur-Silva SEED r119 reference alignment. Sequencing error reduction was
achieved through preclustering, and elimination of chimera carried out with UCHIME [29]. This was
followed by taxonomical classification of the sequences (against the Silva reference classification) and
removal of sequences from domains of life other than Bacteria and Archaea. The resultant number
of 16S rRNA gene and 16S rRNA sequences per sample ranged from 10,767 to 19,244 and 11,616 to
19,397, respectively. Single replicates with less than 1000 sequence reads were excluded from further
analysis. OTU picking by clustering at the 97% identity level (using the cluster.split method) and
OTU consensus taxonomical calling integrating the taxonomical classification of the cluster member
sequences was then performed. The representative sequences of each OTU (with at least two observed
sequences) were queried against a filtered (unknown and unclassified sequences were removed)
version of the ribosomal database project release 11.4 reference. A summary table with the taxonomy
and alignment details for each OTU representative sequence was generated. The OTU abundance table
was variance filtered and normalized (total sum scaling resulting in relative abundances) according to
default settings in the Microbiome Analyst pipeline unless indicated otherwise [30]. Datasets were
rarefied to a uniform sequencing depth of 10,767 sequences per sample for comparative analyses
except for DESeq2 analyses, where the non-rarefied non-normalized datasets were used according
to [31]. Please note that Silva r119 used in the current study classifies the “Betaproteobacteria” as
“Betaproteobacteriales”, an order of the Gammaproteobacteria. Thus, genera and higher taxonomic
ranks that formerly represented “Betaproteobacteria” now belong to “Gammaprotobacteria”.
2.7. Primer Design and Quantification of Total and Taxon-Specific 16S rRNA and 16S rRNA Genes
Quantitative kinetic PCR (qPCR) was used to estimate the numerical abundance of 16S rRNA
gene and 16S rRNA sequences of the total bacterial community as well as of some representative OTUs.
The representative OTUs were chosen for their significantly high differential relative abundance in
the 400 µM ibuprofen treatment amplicon libraries relative to unamended controls as determined
by the DeSeq2 approach (see Figure 3 and Figure S7 and Table S2). To quantify these OTUs, specific
primers were designed in Primer-Blast using the default settings [32]. One primer set targeting an
unclassified OTU affiliated to the class Actinobacteria was obtained from [33] (Table S1). All primers
were tested in silico against target and non-target sequences to ascertain specificity, with verified
primers subsequently synthesized at Microsynth Seqlab (Göttingen, Germany). The fidelity of the
synthesized primers against DNA samples was assessed using PCR and subsequent cloning [34].
The cloned amplicons were subjected to Sanger sequencing and checked against the NCBI nucleotide
database, confirming correct amplification and classification of the targeted taxa. Sequences with a
99% similarity to the targeted taxa were used to generate qPCR standards as previously described [35].
For both total community and specific OTU amplification, DNA and cDNA samples were diluted
100- and 50-fold, respectively, to reduce potential inhibition of qPCR by coextracted PCR-inhibiting
compounds. Spiking assays demonstrated inhibition-free amplifications at such dilutions [35].
Five microliters of DNA or cDNA were used as templates in 20-µL reaction mixtures containing 10 µL
of SensiMix Plus with SYBR Green and Fluorescein (Bioline GmbH, Luckenwalde, Germany), 1.2 µL of
a 50 mM MgCl2 solution, 150 ng/µL of bovine serum albumin, 0.2–1.6 pM of each primer (Biomers, Ulm,
Germany), and nuclease-free water (Thermo Fischer Scientific, Darmstadt, Germany). Each sample was
assayed in technical quadruplicates to determine copy numbers with external standards generated from
the amplified clones using a Bio-Rad iQ5 optical system software version 2.0. (Bio-Rad Laboratories Inc,
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Hercules, CA, USA). The total bacterial community was amplified according to [35]. Briefly, the primer
set 341F/534R, and the following program was used: Initial denaturation at 95 ◦C for 10 min, and
35 cycles of denaturation at 94 ◦C for 30 s, primer annealing at 55.7 ◦C for 40 s, and elongation at 72 ◦C
for 40 s. The final elongation was at 72 ◦C for 5 min. The program for amplification of specific OTUs
was initial denaturation at 95 ◦C for 3 min, and 35 cycles of denaturation at 94 ◦C for 30 s, primer
annealing at the respective temperatures shown in Table S1 for 30 s, and elongation at 72 ◦C for 90 s.
The final elongation was at 72 ◦C for 7 min.
2.8. Statistical Analyses
Alpha diversity was assessed based on Shannon indices and richness estimators using rarefied
sequence data applying post-hoc Tukey test using PAST v3.15 [36]. Differences in bacterial community
compositions across treatments were visually assessed with principal coordinate analysis (PCoA) and
analysis of similarity (ANOSIM) applying the Bray–Curtis distance metric. The linear discriminant
analysis (LDA) effect size (LEfSe) algorithm [37], as implemented in the Microbiome Analyst
pipeline [30], was used to identify specific taxa whose relative abundance changed significantly
over time. All samples were compared against each other, and significant taxa were ranked according
to the difference in their mean relative abundances from all ibuprofen-supplemented samples and
all unamended samples, including t0. The LEfSe analysis was based on three replicates, and a
Kruskal–Wallis test-derived p-value of <0.05 was used to indicate a statistically significant difference.
Potential ibuprofen degraders were identified based on the significant differential abundance values
(p-adj <0.05) between unamended controls and amended treatments using the DESeq2 package [31]
in R (3.5.2) [38]. Genera with a significant Log2FoldChange >0 in ibuprofen treatments relative to
unamended controls were considered enriched. ANOVA and Tukey tests were applied to evaluate the
effect of treatments on total bacteria and OTU-specific 16S rRNA and rRNA gene abundance.
2.9. Enrichment and Isolation of Ibuprofen-Degrading Bacteria from Hyporheic Zone Sediments
The microcosms, amended exclusively with 400µM ibuprofen after 27 days of incubation (Figure 1),
were pooled and a subsample of sediment was obtained and subjected to a serial dilution (1:10 (w/v))
in modified oxic mineral salts medium [39]. The medium contained (in mg L−1) mineral salts (NaCl,
100; (NH4)2SO4, 25; CaCl2 2H2O, 10; MgCl2·6H2O, 10; NH4Cl, 50; KH2PO4, 50), trace elements
(C6H6NNa3O6·H2O, 15; MnSO4·H2O, 5; FeSO4·7H2O, 1; CoCl2·6H2O, 1; CaCl2·2H2O, 1; ZnSO4·7H2O,
1; AlK(SO4)2·12H2O, 0.2; CuSO4·5H2O, 0.1; H3BO3, 0.1; Na2MoO4·2H2O, 0.1), and 10 mL L−1 vitamin
stock solution [40]. Each dilution was supplemented with 400 µM ibuprofen as the only-carbon and
energy source. Sediment dilutions were incubated for 21 days at 15◦C in the dark and ibuprofen
degraders further enriched. The 10−6 dilution was the highest sediment dilution showing turbidity
indicative of growth and was streak-plated onto the same medium solidified with 1% agar. Six isolated
colonies were then transferred to the oxic liquid mineral salts medium containing 400 µM ibuprofen and
tested for ibuprofen-degrading capabilities using HPLC. Two ibuprofen-degradation-positive colonies
were purified via repeated streak-plating, picking of single colonies, and transfer to liquid media
supplemented with ibuprofen. Cell morphology was examined with a Zeiss AxioPlan Fluorescence
Phase Contrast Microscope (ZEISS, Oberkochen, Germany). The homogeneous colony and cell
morphologies indicated the purity of isolates. At least five colonies from each isolate were subjected
to colony PCR, and the 16S rRNA gene was amplified from genomic DNA using the primer set
27F/1492R [41,42] and the following program: Initial denaturation at 94 ◦C for 10 min, and 30 cycles
of denaturation at 94 ◦C for 30 s, primer annealing at 52 ◦C for 40 s, and elongation at 72 ◦C for
90 s. The final elongation was at 72 ◦C for 7 min. Sanger-sequencing reactions were performed
at Microsynth Seqlab (Göttingen, Germany). 16S rRNA gene sequences from all respective isolate
colonies were compared using the NCBI blast search tool with the GenBank database. The similarity
between the five or more 16S rRNA gene sequences from different colonies of one isolate was higher
than 99%. Nearly complete 16S rRNA gene sequences of 1444 and 1380 bases for the two isolates,
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i.e., strains CN1 and MAH1, were obtained. These 16S rRNA gene sequences were aligned with
closely cultured relatives as indicated by blastn analysis against GeneBank using the ARB-SILVA
aligner tool (www.arb-silva.de/aligner). Phylogenetic tree reconstruction was performed using the
Molecular Evolutionary Genetic Analysis (MEGA v7) tool with the neighbor-joining method and
bootstrap analysis [43]. Following the identification of these strains, detailed characterization of the
ibuprofen degraders will be performed in the future.
Microorganisms 2020, 8, x FOR PEER REVIEW 7 of 25 
 
than 99 %. Nearly complete 16S rRNA gene sequences of 1444 and 1380 bases for the two isolates, i.e., 
strains CN1 and MAH1, were obtained. These 16S rRNA gene sequences were aligned with closely 
cultured relatives as indicated by blastn analysis against GeneBank using the ARB-SILVA aligner tool 
(www.arb-silva.de/aligner). Phylogenetic tree reconstruction was performed using the Molecular 
Evolutionary Genetic Analysis (MEGA v7) tool with the neighbor-joining method and bootstrap 
analysis [43]. Following the identification of these strains, detailed characterization of the ibuprofen 
degraders will be performed in the future. 
 
Figure 1. Degradation of ibuprofen in oxic hyporheic zone sediment microcosms. Plots (A–D) 
correspond to sediment amended with ibuprofen concentrations of 5, 40, 200, and 400 µM, 
respectively. Plots (E–H) correspond to sediment amended with both 1 mM acetate and ibuprofen 
concentrations of 5, 40, 200, and 400 µM, respectively. Values are the arithmetic means of triplicate 
oxic incubations. Error bars indicate standard deviations. Some standard deviations are smaller than 
the symbol size and therefore not apparent. Arrows indicate the time of refeeding of microcosms with 
ibuprofen (A–D) and acetate and ibuprofen (E–H), respectively. Red and blue arrows indicate 
sampling of the sediment for nucleic acid extraction after the third and fifth refeeding, respectively. 
Figure 1. Degradation of ibuprofen in oxic hyporheic zone sediment microcosms. Plots (A–D)
correspond to sediment amended with ibuprofen concentrations of 5, 40, 200, and 400 µM, respectively.
Plots (E–H) correspond to sediment amended with both 1 mM acetate and ibuprofen concentrations
of 5, 40, 200, and 400 µM, respectively. Values are the arithmetic means of triplicate oxic incubations.
Error bars indicate standard deviations. Some standard deviations are smaller than the sy bol size
and therefore not apparent. Arrows indicate the time of refeeding of microcosms with ibuprofen (A–D)
and acetate and ibuprofen (E–H), respectively. Red and blue arrows indicate sampling of the sediment
for nucleic acid extraction after the third and fifth refeeding, respectively.
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Accession Numbers
Illumina sequence data were deposited in the NCBI Sequence Read Archive under the accession
number PRJNA529686. Sequences of qPCR standards generated in this study were deposited in the
GenBank nucleotide sequence database under the accession numbers MK732962-MK732969. 16S rRNA
gene sequences of Novosphingobium sp. strain CN1 and Pseudomonas thivervalensis strain MAH1 were
deposited in the GenBank nucleotide sequence database under the accession numbers MK910996 and
MN317372, respectively.
3. Results
3.1. Transformation of Ibuprofen in Hyporheic Zone Sediments
Degradation of ibuprofen in ibuprofen-amended sediment microcosms occurred without an
appreciable delay except for the 400 µM treatment, which exhibited an initial nine-day lag phase
(Figure 1A–D). Ibuprofen was depleted within 11 days for the 5 and 40 µM treatments, and within 16
days for the 200 and 400 µM treatments. In the presence of acetate as a primary carbon source, the
degradation of ibuprofen tended to be delayed across most concentrations after the first amendment
with ibuprofen and acetate (Figure 1E–H). The initial time needed for the depletion of ibuprofen
depended on the initial ibuprofen concentration as well as acetate supplementation and ranged from
11–34 days (Figure 1). After subsequent refeedings, ibuprofen was degraded entirely within 1–3 days
in the presence and absence of acetate, indicating the enrichment of ibuprofen degraders. Ibuprofen
concentrations were essentially constant in control microcosms containing autoclaved sediment and
river water, while ibuprofen was below the detection limit in the unamended microcosms (Figure S1).
Microcosms amended with 200 µM ibuprofen were chosen for in-depth transformation product analysis
as representative treatments with a high initial ibuprofen concentration as well as a quick ibuprofen
degradation after the fourth refeeding. 1-hydroxyibuprofen, 2-hydroxyibuprofen, 3-hydroxyibuprofen,
and carboxyibuprofen were transiently detected in concentrations accounting for less than 1% of the
initially supplied ibuprofen, suggesting that such compounds were transformation intermediates
(Figure S2).
3.2. Effect of Treatments on Bacterial Community Structure and Composition
3.2.1. Total Bacterial Abundance and Diversity
The total bacterial 16S rRNA gene abundance in the ibuprofen treatments and controls based
on samples assessed after the third and fifth refeeding was essentially similar (ANOVA, p > 0.05)
(Figure S3). The 16S rRNA gene abundance tended to be higher in unamended controls relative to
ibubrofen-amended treatments, and after the third relative to the fifth refeeding. Such a pattern was
less prominent on the rRNA level. The 16S rRNA abundance was, however, significantly higher in
treatments relative to unamended controls after the third refeeding but lower than the unamended
controls after the fifth refeeding (ANOVA, p < 0.05) (Figure S3). The alpha diversity from samples
taken after the third and fifth refeeding revealed a significantly lower Shannon diversity (ANOVA,
p ≤ 0.05) at the OTU level in samples amended exclusively with ibuprofen or ibuprofen-acetate relative
to unamended controls (Figure S4). Species richness and evenness tended to follow the same trend;
however, differences were not significant (ANOVA, p > 0.05) (Figure S4). Beta diversity visualization
using principal coordinate analysis (PCoA) based on Bray–Curtis distances indicated that microbial
communities in ibuprofen and ibuprofen-acetate treatments were distinct from the unamended controls
and original sediment before incubation based on 16S rRNA gene and 16S rRNA sequences, respectively
(Figure 2A,B). Consistently, two-way ANOSIM tests indicated that in samples amended exclusively
with ibuprofen, both ibuprofen treatment (DNA: R = 0.7, RNA: R = 0.63, p < 0.0001) and incubation time
(DNA: R = 0.98, RNA: R = 0.98, p < 0.0001) contributed significantly to the differences in the microbial
community composition among the samples. Similarly, the ibuprofen-acetate treatment (DNA: R = 0.75,
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RNA: R = 0.72, p < 0.0001) and incubation time (DNA: R = 1, RNA: R = 0.99, p < 0.0001) also contributed
significantly to the differences in the microbial community composition of the corresponding samples.
The R-values greater than 0.6 indicated a rather strong dissimilarity between microbial communities
from different treatments and time points. Communities from treatments amended with low and high
ibuprofen concentrations (i.e., 5–40 and 200–400 µM, respectively) formed clusters separated along
axis 1, suggesting a dose-dependent effect of ibuprofen (Figure 2A,B).
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Figure 2. Principal coordinate analysis of the Bray–Curtis dissi ilarity etric sho ing the effect of
ibuprofen and ibuprofen/acetate treatments on the bacterial community composition based on OTUs
from the 16S rRNA gene (panel A) and 16S rRNA (panel B). Sample code: A, amended with 1 mM
acetate and ibuprofen per feeding; 0, 5, 40, 200, and 400 indicate supplemental ibuprofen concentrations
of 0, 5, 40, 200, and 400 µM, respectively, given per feeding; 0′, 3′, and 5′, correspond to samples
obtained at the start of the incubation, and after the third and fifth refeeding, respectively. Sampling
times for unamended controls were according to those of the 400 µM ibuprofen treatment.
3.2.2. General Phylum-Level Taxonomic Composition
Because of the scarcity of cultured ibuprofen degraders, structural genes associated with ibuprofen
degradation as well as PCR assays targeting such genes are lacking. Hence, the 16S rRNA gene
and transcript were targeted to characterize the response of the bacterial community after ibuprofen
addition. The dominant phyla (>1% relative abundance) on both DNA and RNA levels were
Proteobacteria, Chloroflexi, Acidobacteria, and Actinobacteria, followed by Firmicutes, Bacteroidetes,
Gemmatimonadetes, Latescibacteria, and Nitrospirae (Figure S5A,B). Such phyla were among the
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significant top 10 based on the linear discriminant analysis (LDA) score on the DNA and RNA level,
explaining differences among treatments (Figure S5C). The relative abundance of Proteobacteria,
Acidobacteria, Bacteroidetes, Gemmatimonadetes, and Latescibacteria tended to increase in the
presence of ibuprofen or ibuprofen and acetate (Figure S5). Actinobacteria and Chlorobi showed a
variable response to the treatments when the DNA and RNA levels were compared. Interestingly,
Acidobacteria, Gemmatimonadetes, and Latescibacteria appeared to be stimulated in treatments with
low concentrations of ibuprofen (5–40 µM) in the absence of supplemental acetate on the DNA and
RNA level. Proteobacteria were most abundant in amplicon libraries of treatments with acetate
and high concentrations of ibuprofen (200–400 µM). Such a finding was attributed primarily to the
Gammaproteobacteria, whose relative abundance was significantly higher relative to unamended
controls (ANOVA, p < 0.05). Bacteroidetes responded to all ibuprofen concentrations with a high
relative abundance in amplicon libraries. Such a high relative abundance was particularly prominent
on the RNA level in treatments with high concentrations of ibuprofen (200–400 µM). Chloroflexi,
Firmicutes, and Nitrospirae tended to decrease on average in relative abundance in response to
ibuprofen. Archaeal sequences were generally less abundant than bacterial sequences in amplicon
libraries, and affiliated primarily with Thaumarchaeota and Euryarchaeota. Likewise, they tended to
decrease in response to ibuprofen treatments on the DNA and RNA level except for Thaumarchaeota,
which tended to be stimulated on the RNA level with low ibuprofen concentrations.
3.2.3. Family-Level Taxonomic Composition
Pseudomonadaceae, Sphingomonadaceae, and Commamonadaceae were the families with the highest
LDA scores that had on average higher relative abundances in ibuprofen treatments compared to
non-supplemented controls on the DNA and RNA level (Figure 3A), which was likewise reflected in the
OTU-based analysis (Figure S6A,B) and the following phylum-level analysis. Notably, such families
were consistently crucial in ibuprofen and ibuprofen-acetate treatments. Other families that had high
LDA scores and higher relative abundances in amplicon libraries from ibuprofen treatments compared to
non-supplemented controls on the DNA and RNA level included Gemmatimonadaceae, Xanthomonadaceae,
Nocardioidaceae, Flavobacteriaceae, Sandaracinaceae, and Cytophagaceae (Figure 3A), suggesting that
members of these families were stimulated in ibuprofen treatments. Bdellovibrionaceae was likewise
stimulated. In contrast, LDA scores of family-level taxa that had lower relative abundances in ibuprofen
treatments compared to non-supplemented controls on the DNA and RNA level suggested a negative
impact of ibuprofen (Figure 3B). Many well-known anaerobes (e.g., Caldilineaceae, Peptostreptococcaceae,
Desulfobacteraceae, and Syntrophaceae), as well as aerobic nitrifiers of the Nitrospiraceae and uncultured
families, met such a criterion, suggesting that anaerobic processes, such as primary and secondary
syntrophic, fermentations, and nitrification, might be impaired by ibuprofen.
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Figure 3. Linear discriminant analysis (LDA) scores on the DNA and RNA levels for families that were
more (A) or less (B) abundant in treatments with ibupr fen relative to non-supplemented controls and
displayed a consistent response on the DNA nd RNA level.
3.2.4. OTU-Level Taxa Associated with Ibuprofen Degradation
Differential abundance analysis was performed to identify ibuprofen-responsive OTU-level taxa.
Taxa whose abundances significantly (p < 0.05) changed in ibuprofen treatments relative to unamended
controls (log2foldchange > 0.5) were considered enriched and thus candidate taxa for representing
ibuprofen degraders. Many OTUs (78 to 92) were enriched in ibuprofen treatments representative for
high and low ibuprofen amendments (400 and 40 µM, respectively; Table S2). Consistent with the
analyses on the phylum and family levels, OTUs enriched in response to ibuprofen affiliated primarily
with Acidobacteria; Alpha-, Gamma-, and Deltaproteobacteria; Bacteroidetes; Gemmatimonadetes; and
Latescibacteria. Cumulated log2fold change values in response to ibuprofen relative to unamended
controls suggested a preferential enrichment of OTUs affiliating with Acidobacteria, Chloroflexi,
Deltaproteobacteria, Gemmatimonadetes, Latescibacteria, and Saccharibacteria in treatments with low
ibuprofen concentrations (40 µM) on the DNA level (Figure 4, Table S2). In contrast, OTUs affiliating
with Alpha- and Gammaproteobacteria, Actinobacteria, Bacteroidetes, and Verrucomicrobia were more
enriched in treatments with high ibuprofen concentrations (400 µM;) Figure 4). OTUs affiliating with
Alpha-, Gamma-, and Deltaproteobacteria; Actinobacteria; and Chlorobi tended to be stimulated by
supplemental acetate.
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Figure 4. Log2fold change of ibuprofen-responsive OTUs summed up for all OTUs affiliating with
the same (sub-) phylum (based on data from Table S2). A, DNA; B, RNA (cDNA). OTUs significantly
enriched by ibuprofen relative to unamended controls sampled at the same time point had a Log2-fold
change >0 at p-adj < 0.05. IBU40 and IBU400, ibuprofen amendment with 40 and 400 µM ibuprofen,
respectively. IBA40 and IBA400, ibuprofen amendment with 40 and 400 µM ibuprofen, respectively,
together with 1 mM acetate.
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Proteobacterial OTUs dominated ibuprofen-responsive taxa in general. Such taxa
included alphaproteobacterial Novosphingobium, Hyphomicrobium, and Woodsholea-affiliated OTUs;
Gammaproteobacterial (Betaproteobacteriales affiliating) OTUs related to Hydrogenophaga, Piscinibacter,
and Vogesella; Gammaproteobacteria OTUs related to Pseudomonas and Arenimonas; as well as
OTUs affiliating with Bdellovibrio and distantly related to Sandaracinus. Rhodococcus, Iamia,
Aquihabitans, Nocardioides, and Fodinicola related OTUs along with uncultured taxa were significant
among the Actinobacteria. Ibuprofen-enriched important taxa of the Bacteroidetes included
Chryseolinea, Ferruginibacter, Flavobacterium, and uncultured taxa. Ibuprofen-enriched OTUs of
the Gemmatimonadaceae and Latescibacteria were distantly related to Gemmatimonas sp. and
to uncultured organisms, respectively. OTUs affiliating with subgroups 6, 17, and 22 within the
Acidobacteria were enriched in response to ibuprofen. Notably, certain phyla that showed on
average a generally variable or even negative response to ibuprofen nevertheless contained OTUs
that were enriched in response to ibuprofen (Table S2), demonstrating the need for high taxonomic
resolution on the OTU level. Such phyla were Chloroflexi (Figure 4, Table S2), Chlorobi (e.g., OTUs
93 and 740), Nitrospirae (e.g., OTU 7 related to Nitrospira moscoviensis), and Verrucomicrobia (e.g.,
OTU 162 related to Prosthecobacter sp.). Hitherto uncultured groups (e.g., NS9_marine_group, env.
OPS_17, KD4-96; Table S2) enriched by ibuprofen indicate new potential ibuprofen degraders in
hyporheic zone sediments. Most of the OTUs enriched in ibuprofen treatments following incubation
were detected in the original community and/ or the unamended controls (Table S3). OTUs 1,
15, 32, 95, 39, and 93, indicative of Novosphingobium sp. (Alphaproteobacteria), Fodinicola sp.
(Actinobacteria), uncultured Gemmatimonadetes, uncultured Latescibacteria, Acidobacterial subgroup
17, and uncultured Chloroflexi of the BSV26 group, respectively, had relative abundances of greater
than 0.1% in the original community on the DNA level in the non-rarified dataset (data not shown).
3.3. Quantification of Representative Ibuprofen-Enriched OTUs
An increase in relative abundance in amplicon libraries does not necessarily indicate stimulation.
Thus, qPCR was utilized to verify ibuprofen-stimulated taxa as indicated by relative abundance data
(see previous sections) using 16S rRNA (cDNA) to 16S rRNA gene ratios as an indicator of taxon-specific
activity. Representative OTUs were selected based on significantly higher expression of 16S rRNA
genes (ANOVA, p ≤ 0.05) in 400 µM ibuprofen treatments relative to unamended controls (Figure 5,
Table S1), which agreed with the Deseq2 differential abundance data analysis. This highlighted the
reliability of the differential abundance approach to identify potential ibuprofen-responsive taxa in
hyporheic zone sediment microcosms.
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3.4. Ibuprofen-Degrading Strains CN1 and MAH1
The two strains isolated from the 400 µM ibuprofen-only treatments (Figure 1), affiliated with
ibuprofen-responsive OTUs 1 (Novosphingobium related) and 24 (Pseudomonas related; Figure 5).
These representative OTUs for Sphingomonadaceae and Pseudomonadaceae, respectively, were present in
the original hyporheic zone community prior to incubation at a relative abundance of approximately
0.01–0.1%, and stimulated by ibuprofen on the DNA and RNA level (Figure 6A,B and Figure S6;
Table S2). The stimulation of OTU 1 generally resulted in higher relative abundances than OTU 24 and
tended to be most prominent in treatments with low ibuprofen concentrations (Figure 5). The relative
abundance of OTU 24 was more similar across all treatments. 16S rRNA gene similarities of CN1
and MAH1 to representative sequences of OTUs 1 and 24, respectively, were >97%. Strain CN1
consumed approximately 400 µM of ibuprofen within two days (Figure 6A). CN1 had a 16S rRNA
gene similarity of 96.8% and 96.3% to the Novosphingobium flavum strain UCM-28 (Acc. Nr. NR_152007)
and N. aromaticivorans strain IFO 16084 (Acc. Nr. NR_112090), respectively, and clustered with
other organisms of the genus Novosphingobium (Figure S7A), suggesting that strain CN1 represents a
new ibuprofen degrader of the genus. Strain MAH1 consumed approximately 300 µM of ibuprofen
within eight days (Figure 6B). A 16S rRNA gene similarity of 99.9% of MAH1 to Pseudomonas
thivervalensis (Acc. Nr. KF528727) and clustering with P. thivervalensis (Figure S7B) suggests MAH1 as
an ibuprofen-degrading strain of this species.
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Figure 6. Effect of ibuprofen on the relative abundance of OTUs in 16S rRNA gene (DNA) and 16S
rRNA (RNA or cDNA)-derived amplicon libraries from oxic hyporheic zone sediment microcosms
(Figure 1) affiliating with ibuprofen-degrading strains Novosphingobium CN1 (A) and Pseudomonas
MAH1 (B), and the capacity of both strains to degrade ibuprofen under oxic conditions. The grey
box indicates unsupplemented oxic control microcosms. Values represent the arithmetic means of
triplicates, and error bars indicate standard deviations. Filled and open circles, DNA and RNA (cDNA)
level, respectively; filled squares, ibuprofen concentration. Sample code: A, amended with 1 mM
acetate and ibuprofen per feeding; 0, 5, 40, 200, and 400 indicate supplemental ibuprofen concentrations
in µM given per feeding; 0′, 3′, and 5′ correspond to samples obtained at the start of the incubation,
and after the third and fifth refeeding, respectively. Sampling times for unamended controls were
according to those of the 400 µM ibuprofen treatment.
4. Discussion
4.1. Biodegradation of Ibuprofen in the Hyporheic Zone Sediments
Microbial degradation of ibuprofen was demonstrated in the hyporheic zone sediments (Figure 1).
Thus, our findings extend previous studies reporting the attenuation of ibuprofen in engineered
and natural environments [6,9–12,44]. Consistent with previous studies [45,46], abiotic losses due
to sorption and hydrolysis played a marginal role in total ibuprofen removal, demonstrating that
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ibuprofen removal was indeed mainly due to biodegradation (Figure S1). The ibuprofen concentration
was observed to influence the rate of degradation after the first feeding. The 400 µM ibuprofen
treatment exhibited a nine-day lag phase in contrast to lower concentrations, whose disappearance
exhibited no significant delay. This is likely attributable to an inhibitory effect on the microbial activity
as has been reported for ibuprofen concentrations exceeding 50 mg L−1 (242 µM) in which a decline
in oxygen respiration and microbial diversity was observed in activated sludge [47]. Subsequent
rapid depletion of ibuprofen following refeeding irrespective of the initial concentration suggests a
rapid enrichment of microbes capable of ibuprofen degradation and thus adaption of the microbial
community (Figure 1A–D). A similar pattern was reported in a recent study [47], where an activated
sludge microbial community adapted to high concentrations of ibuprofen (5000 mg L−1; 24 mM) after
long-term exposure, suggesting a rather high limit for ibuprofen tolerance.
Microcosms containing supplemental acetate as the primary carbon source exhibited a delayed
onset of ibuprofen degradation following initial spiking (Figure 1). This is in contrast to ibuprofen
oxidation by enzymes activated during the initial degradation of acetate rather than ibuprofen,
a phenomenon associated with cometabolic degradation [12]. The preferential consumption of
acetate by the indigenous hyporheic zone bacteria capable of ibuprofen consumption is a more
likely explanation, considering that acetate is a more easily degradable substrate than ibuprofen.
In the latter case, ibuprofen is likely degraded upon acetate depletion. Refeeding the microcosms
with ibuprofen-acetate, however, exhibited a rapid ibuprofen degradation similar to ibuprofen-only
microcosms, suggesting that ibuprofen degraders were enriched in the absence and presence of
supplemental acetate. In most cases, similar taxa were stimulated in treatments with ibuprofen only
and acetate/ ibuprofen (Figure S6), supporting the view that metabolic degradation of ibuprofen was
significant in the sediments and that many taxa in the hyporheic zone are prone to respond to ibuprofen
as a source of carbon and energy.
The different transformation intermediates 1-, 2-, 3-hydroxy- and carboxyibuprofen were
transiently observed during ibuprofen degradation (Figure S2). Moreover, these ibuprofen degradation
intermediates were likewise detected previously in situ in the river Erpe hyporheic zone sediments [22],
indicating ongoing ibuprofen biodegradation in situ as a primary attenuation mechanism for ibuprofen
and the utilization of different metabolic pathways characteristic of a diverse bacterial community
(Figure S8).
Indeed, previous studies using pure cultures have shown variable biodegradation pathways for
ibuprofen [48]. 2-hydroxyibuprofen was the most abundant transformation intermediate detected
during ibuprofen degradation in the hyporheic zone sediments (Figure S2). 2-hydroxyibuprofen is
generated by an aliphatic monooxygenase activity followed by a series of other enzymes, leading to
the eventual production of 3-hydroxy-cis,cis-muconic acid, which enters the tricarboxylic acid cycle in
Bacillus thuringiensis B1 [15]. Nocardia NRRL 5646 was shown to employ a carboxylic acid reductase
enzyme system that reduces the carboxylic functional group of ibuprofen to the corresponding alcohol,
which is then acetylated [49]. Thus, one of the initial reactions of ibuprofen utilization in our microcosms
was the transformation of the aliphatic chain as observed with such isolates and other environmental
samples [9,18].
Further characterized ibuprofen degraders producing degradation intermediates not
detected in our study include Sphingomonas Ibu-2 and Variovorax Ibu-1. Sphingomonas Ibu-2
hydroxylates ibuprofen to isobutylocatechol following CoA ligation, which is then cleaved to
5-formyl-2-hydroxy-7-methylocta-2,4-dienoic acid, before oxidation to 2-hydroxy-5-isobutylhexa-2,
4-dienedioic acid [13,50]. Variovorax Ibu-1 degrades ibuprofen via ring-hydroxylated ibuprofen [14].
However, such degradation intermediates were only detected when further metabolism was inhibited
by 3-fluorocatechol, suggesting that such intermediates are subject to rapid turnover and will escape
detection during routine analyses. 1,2-dihydroxyibuprofen has previously been reported as a probable
dead-end product of fungal ibuprofen metabolism [51]. As these compounds were not measured in the
current study, conclusions on the importance of such ibuprofen degradation pathways in our sediment
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microcosms remain elusive. Nevertheless, all of the biodegradation pathways named above converge
in the tricarboxylic acid cycle, allowing for the assimilation of ibuprofen carbon and potentially the
mineralization of ibuprofen to CO2. The cumulative findings of the current study, i.e., the enrichment
of many taxa in response to ibuprofen (Figure 4, Table S2), the acceleration of ibuprofen degradation
during incubation (Figure 1), utilization of ibuprofen by the two isolates as the only carbon and energy
source to support their growth (Figure 6), the lack of inhibitory effects on ibuprofen degradation
after five refeedings (Figure 1), and the disappearance of the ibuprofen transformation products
(Figure S2), argue in favor of mineralization and assimilation of ibuprofen carbon by hyporheic zone
sediment microorganisms.
4.2. Bacterial Community Structure and Diversity
The significant increase in 16S rRNA-based copy numbers and sequence abundance in
ibuprofen-amended samples relative to controls after the third refeeding (Figures S3 and S5), suggests
a strong stimulation of specific ibuprofen responders, since rRNA abundance serves as a proxy for
activity [52]. The decline in rRNA abundance in most treatments after the fifth refeeding corresponds
with the sampling, which was carried out at the end of the incubation when ibuprofen was almost
depleted in most microcosms (see Figure 1). Despite a significant decline in the Shannon diversity
index (ANOVA, p < 0.05) in the high ibuprofen treatments (200 and 400 µM; Figure S4), the River Erpe
hyporheic zone sediments hosted a taxonomically diverse microbial community (Figures S4 and S5;
Table S2). Accumulating evidence suggests a positive correlation between taxonomic diversity and
some specific microbially mediated processes, such as micropollutant degradation [53,54].
4.2.1. Generalized Ecological Niches of Ibuprofen-Responsive Phyla
OTUs affiliating with the phyla Proteobacteria, Bacteroidetes, Chloroflexi, Acidobacteria,
Actinobacteria, and Gemmatimonadetes were particularly shown to positively respond to ibuprofen
amendment (Figure 4, Figures S5 and S6). The higher degradation rates with subsequent ibuprofen
addition (after initial lag; Figure 1), concurrent with the high 16S rRNA gene/transcript abundance
ratio in amended relative to unamended sediment samples (Figure 5), suggested that members of
these phyla were enriched and dominated the degrader population. Previously, Proteobacteria and
Bacteroidetes were observed in studies on a subsurface flow-constructed wetland system treating
ibuprofen-contaminated wastewater, and in oxic ibuprofen-amended microcosms with activated
sludge [6,47], indicating the presence and response to ibuprofen of members belonging to these
key phyla in diverse environments. Proteobacteria were the most responsive to high ibuprofen
concentrations (Figure 4 and Davids et al. [47]). Their response may be attributed to their general
functional traits as aromatic compound degraders and the capability to quickly respond to substrate
availability [55,56]. Microcosms with acetate as a primary substrate exhibited similar patterns
relative to ibuprofen-only treatments in terms of relative phylum abundance (Figure S5). However,
the relative abundance of Gammaproteobacteria was significantly higher (ANOVA, p < 0.05) in
ibuprofen-acetate-containing than in ibuprofen-only microcosms. This would indicate that the
Gammaproteobacteria stimulated by ibuprofen are likewise capable of acetate utilization.
Members of the different phyla, such as Acidobacteria, Gemmatimonadetes, and Latescibacteria,
positively responded to lower ibuprofen concentrations (5 and 40 µM) and less to higher concentrations
(200 and 400 µM), while the opposite was observed for Proteobacteria (Figure 4, Figure S5), suggesting
that some bacteria can use micropollutants as a substrate within a certain range of concentrations, above
which it turns toxic or inhibitory. Thus, our study suggests distinct ecological niches for Proteobacteria
that reflect the lifestyles of r-strategists, and Acidobacteria, Gemmatimonadetes, and Latescibacteria
that reflect the lifestyles of K-strategists.
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4.2.2. Putative Taxa Associated with Degradation of Ibuprofen in Oxic Hyporheic Zone Sediments
New and known bacteria enriched in ibuprofen-amended microcosms relative to unamended
controls were associated with degradation of ibuprofen (Figure 4 and Figure S6, Table S2). Using 40
and 400 µM ibuprofen concentrations as representative concentrations for low and high ibuprofen
concentrations, diverse families and genera from many phyla were enriched. Some of these bacteria
were also observed in microcosms with intermediate ibuprofen concentrations (Figure S6). Moreover,
most of the enriched taxa were detected in the original hyporheic zone sediment bacterial community,
suggesting their involvement in ibuprofen degradation in situ (Table S3).
Stimulation of Proteobacteria-affiliated taxa by ibuprofen was most significant (Figure 4 and
Figures S5, S6; Table S2). The enrichment of members belonging to the Alphaproteobacteria, such
as Sphingomonadaceae and Hyphomonadaceae, corresponded to previous studies in which genera
belonging to these families were associated with the degradation of xenobiotics [26,57,58]. Moreover,
Hyphomicrobium, a genus from the family Hyphomicrobiaceae, has been previously associated with
assimilation of 2,4-dichlorophenol, a soil and groundwater contaminant [26]. Genera closely related
to Sphingopyxis, Sphingorhabdus, and Novosphingobium affiliating with the ibuprofen-enriched family
Sphingomonadaceae have been isolated from a wide variety of environments, including freshwater and
marine sediments, and were associated with the degradation of a wide variety of natural aromatic
compounds and xenobiotics [59,60]. The ibuprofen degradation kinetics of Novosphingobium strain
CN1 isolated in this study showed a high capacity to quickly degrade ibuprofen (Figure 5) and were in
the range of ibuprofen degradation rates observed after the fifth refeeding of ibuprofen in hyporheic
zone sediments (Figure 1). The high relative abundance of CN1 representing OTU 1 in treatments
with low rather than with high concentrations of ibuprofen suggest that the Novosphingobium strain
CN1 represents a copiotrophic organism whose growth is impaired in situ in the presence of high
ibuprofen concentrations. The isolation of the ibuprofen-degrading Novosphingobium strain CN1 in this
study along with the ibuprofen-degrading Sphingomonas IBU-2 [13] extends previous observations to
hyporheic zones, consolidates correlations, and emphasizes the biodegradation potential associated
with Sphingomonadaceae.
New and known members of the Betaproteobacteriales (considered as part of the
Gammaproteobacteria) family Comamonadaceae exhibited a positive association with ibuprofen.
Comamonadaceae is among the families with members previously reported to aerobically degrade
aromatic compounds [26]. One of the characterized ibuprofen degraders belonging to this family is
Variovorax Ibu-1 [14]. In a study exploring the co-occurrence patterns between organic micropollutants
and bacterial community structure, the ibuprofen-enriched genus Hydrogenophaga (Comamonadaceae)
was among bacteria significantly correlated to micropollutants and believed to host enzymes for the
biotransformation of specific micropollutants [61]. The ibuprofen-enriched genus Piscinibacter, whose
closest cultivated relative Piscinibacter aquaticus (basonym: Methylibium aquaticum) was isolated from a
eutrophic freshwater pond [62], and the family Oxalobacteraceae were hitherto unassociated with the
degradation of aromatic compounds (Figure 4, Figure S5 and S6; Table S2). However, these taxa belong
to the order Burkholderiales, whose other families, including Comamonadaceae, are associated with such
potentials. It is, therefore, likely that Burkholderiales members may have ibuprofen biotransformation
potential. Enrichment of unknown genera belonging to the family Nitrosomonadaceae by ibuprofen
corroborates the reported potential of members of this family, such as Nitrosomonas, in bioremediation.
Through the activity of ammonia monooxygenase, most ammonia-oxidizing bacteria in this family
can co-metabolize micropollutants [12]. Potential indirect effects like enhanced ammonia release from
biomass turnover due to ibuprofen-stimulated microbial predation (see below) and ammonification
might even allow for enhanced growth of certain nitrifiers in the presence of ibuprofen.
Significant enrichment of the Gammaproteobacterial family Pseudomonadaceae in ibuprofen
treatments is in congruence with previous findings, where Pseudomonadaceae was reported to be involved
in the biodegradation of polyaromatic compounds, such as naphthalene [59]. The genus Pseudomonas
accommodates many isolates capable of aromatic compound degradation [55]. Our isolate Pseudomonas
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thivervalensis MAH1 grew with ibuprofen as the sole carbon and energy source, demonstrating the
ibuprofen degradation capabilities of this genus (Figure 6B). Interestingly, the relative abundance of OTU
24 indicative of the strain MAH1 was essentially similar in all ibuprofen treatments, although ibuprofen
degradation of MAH1 was rather slow (Figure 5). Such data suggest that Pseudomonas thivervalensis
MAH1 represents an oligotrophic organism with a high ibuprofen tolerance. The ibuprofen-enriched
genus Arenimonas (Xanthomonadaceae) has been previously associated with degradation of drugs, such
as penicillin and carbamazepine, in activated sludge and contaminated soils [63], highlighting the
importance of Gammaproteobacteria for biodegradation.
The ibuprofen-enriched Deltaproteobacteria were from the orders Myxococcales and
Bdellovibrionales (Figure 4, Figures S5 and S6; Table S2). Myxococcales degrade complex organic
substrates, possess sophisticated secondary metabolism, and have a predatory lifestyle [64,65].
Bdellovibiro sp. enriched in response to ibuprofen indicated the stimulation of a group recognized as
predatory organisms feeding on Gram-negative bacteria [66]. Predation on Gram-negative ibuprofen
degraders might likewise increase the microbial biomass turnover and thus represent a source of
variation in the data set, limiting ibuprofen-dependent stimulation. Thus, we suggest that the
enrichment of Deltaproteobacteria in ibuprofen treatments is due to indirect effects, i.e., stimulation
of ibuprofen-degrading Gram negatives serving as prey, rather than due to the direct ibuprofen
degradation capabilities of this group.
Many taxa affiliated with Actinobacteria were also enriched in response to ibuprofen (Figure 4,
Figures S5 and S6; Table S2). This phylum is known to accommodate many species involved in
the degradation of complex compounds, including phenol, diesel oil, n-alkanes, and polycyclic
aromatic hydrocarbons [1,55,67]. Such taxa included Rhodococcus sp. and Nocardioides-related OTUs.
Both genera are well known for their capabilities to degrade aromatic compounds [55]. Previously,
the Nocardia strain NRRL 5646 of the Actinobacteria that transformed ibuprofen using the carboxylic
acid reductase enzyme system has been characterized [49]. Fodinicola sp., closely related to the
pesticide-degrading genus Streptomyces [68], a new Iamia related and Illumatobacter sp. were further
examples for ibuprofen-enriched taxa. Ilumatobacter sp. was among Actinobacteri-affiliated taxa
previously considered as potential indicators for exposure to organic pollutants [69], further highlighting
the importance of known and hitherto undetected taxa of the Actinobacteria for biodegradation of
pollutants in the environment.
Ibuprofen-enriched genera affiliating with the phylum Bacteroidetes include Terrimonas and
Ferruginibacter (family Chitinophagaceae, order Sphingobacteriales; (Figure 4, Figures S5 and S6;
Table S2). Terrimonas has been shown to degrade benzo[a]pyrene, a polycyclic aromatic hydrocarbon
(PAH) [70]. The genes encoding the PAH-ring hydroxylating dioxygenase enzymes involved in the
first hydroxylation steps of benzo[a]pyrene and other PAHs under aerobic conditions may predictably
be involved in ibuprofen degradation. Flavobacterium, a genus in the family Flavobacteriaceae, was also
stimulated in ibuprofen treatments as also previously reported [6]. Members of this genus have been
isolated on 2,4-dichlorophenol [71] and also associated with the transformation of pharmaceuticals [72],
suggesting capabilities for aromatic compound degradation. Bacteroidetes-affiliated genera like
Chryseolinea and other unclassified genera in the family env. OPS_17 (order Sphingobacteriales)
were positively associated with ibuprofen amendment, extending the reported association of the
phylum with the degradation of high-molecular-weight organic compounds, including petroleum
hydrocarbons [73], and supporting the view that Bacteroidetes include environmentally relevant
aerobic pollutant degraders.
Few uncultured taxa from low-abundance phyla whose ecophysiology is not well characterized
were also enriched in ibuprofen treatments, suggesting their potential contribution to the degradation
of ibuprofen. Enrichment of hitherto unclassified families belonging to subgroups 6, 17, 22, and
other Acidobacterial families in the phylum Acidobacteria in response to ibuprofen extends previous
reports on the association of members of this phylum with the degradation of contaminants like
polychlorinated biphenyls [74], and petroleum compounds [75]. Taxa of the phyla Gemmatimonadetes
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and Latescibacteria responded to ibuprofen treatments. Gemmatimonas aurantiaca is capable of utilizing
benzoate as the sole carbon and energy source, and the genus Gemmatimonas was related to linear
alkylbenzene sulfonate degradation in a bioreactor [57]. Thus, there is some support for the hypothesis
that such uncultured taxa are likewise involved in ibuprofen degradation [67]. However, even less
information is available for other ibuprofen-stimulated uncultured taxa of the Armatimonadetes,
Chloroflexi, Chlorobi, and some Candidate divisions (Table S2), demonstrating the need for further
research to consolidate the role of such taxa for biodegradation.
5. Conclusions
Microbial degradation of micropollutants, usually occurring in the ng to µg L−1 range, is a
critical attenuation mechanism in the hyporheic zone [22]. Evidence for the capability of microbes to
respond to in situ relevant minute concentrations of organic compounds comes from biosensor studies
utilizing isolates obtained by enrichments with high growth-supportive substrate concentrations.
Concentrations of organic compounds down to the pg L−1 range suffice to induce the transcription
of catabolic genes associated with the degradation of such compounds, demonstrating that microbes
growing on high substrate concentrations also respond to trace quantities of their substrate by
consuming it (e.g., [76]). Thus, microbes enriched with ibuprofen concentrations higher than those
usually occurring in situ have a high likelihood of being capable of degrading ibuprofen at in situ
relevant concentrations in the hyporheic zone.
Primarily, Proteobacteria along with diverse hitherto unknown and known microbes were
associated with the degradation of ibuprofen based on a correlative data set of relative abundance
data from 16S rRNA and 16S rRNA gene amplicons. qPCR of selected taxa and calculation of the
ratio of 16S rRNA to 16S rRNA genes as an indicator of a potential specific activity [77] supported
the relative abundance data. Isolation of ibuprofen degraders provided causality for the ibuprofen
enrichment of two OTUs and their ibuprofen degradation capabilities. Such OTUs likewise indicated
that isolated ibuprofen degraders were present in situ and prone to quickly respond to the presence of
ibuprofen. In the absence of characterized functional genes associated with emerging micropollutants,
phylogeny-based analysis of microbial communities provides an alternative step to understand the
interaction between potential degraders and the micropollutants. Thus, by exploiting complementary
data from process studies, 16S rRNA and 16S rRNA gene amplicon sequencing data, the ratio of 16S
rRNA to 16S rRNA genes as an indicator of the potential activity of bacterial taxa, and characterization
of isolates, we provide evidence for many hitherto unknown ibuprofen degraders and provide
new ibuprofen-degrading model organisms relevant for an important ecosystem service in a poorly
characterized environment from a microbiological perspective.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2607/8/8/1245/s1,
Figure S1: Control microcosms for the ibuprofen degradation experiment (Figure 1). ‘Non-supplemented’
represents the unamended sediment. The abiotic controls ‘Sorption’ and ‘Hydrolysis’ contained autoclaved
sediment and river water, respectively, and were amended with 200 µM ibuprofen. Value s are the arithmetic
means of three replicate incubations. Red and blue-headed arrows indicate sampling of the sediment for nucleic
acids extraction after third and fifth re-spiking, respectively. Error bars indicating standard deviations are smaller
than the size of the symbols and therefore not apparent. Figure S2: Ibuprofen transformation products in oxic
hyporheic zone sediment microcosms amended with 200 µM of ibuprofen (4th respike; see Figure 1B). Values are
the arithmetic mean of three replicate incubations, and error bars indicate standard deviations. Some standard
deviations are smaller than the symbol size and therefore not apparent. Figure S3: Copy numbers of the 16S rRNA
gene and 16S rRNA detected in total bacterial community. Sample code: A, amended with 1 mM acetate and
ibuprofen per feeding; 0, 5, 40, 200, and 400, indicate supplemental ibuprofen concentrations of 0 µM, 5 µM, 40 µM,
200 µM and 400 µM, respectively, given per feeding; 0′, 3′, and 5′, correspond to samples obtained at the start of
the incubation, and after the third and fifth refeeding, respectively. Sampling times for unamended controls were
according to those of the 400 µM ibuprofen treatment. Values are the arithmetic average of three replicates. Error
bars indicate standard deviation values. Figure S4: Alpha diversity and richness estimators of 16S rRNA gene
and 16S rRNA obtained from Illumina amplicon sequencing. Sample code: A, amended with 1 mM acetate and
ibuprofen per feeding; 0, 5, 40, 200, and 400, indicate supplemental ibuprofen concentrations of 0 µM, 5 µM, 40 µM,
200 µM and 400 µM, respectively, given per feeding; 0′, 3′, and 5′, correspond to samples obtained at the start of
the incubation, and after the third and fifth refeeding, respectively. Sampling times for unamended controls were
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according to those of the 400 µM ibuprofen treatment. Values are the arithmetic average of three replicates. Error
bars indicate standard deviation values. Figure S5: Relative abundance of major bacterial (greater than 1% relative
abundance) and archaeal phyla on DNA (A) and RNA (cDNA, B) level, as well as corresponding LDA scores (C).
Archaea are indicated by the grey box. Values and error bars represent means from all time points per treatment
(see Figure 1 and Table S1) of up to 12 samples and standard deviation, respectively. 0, unamended controls; 5–40,
‘low ibuprofen treatments’ with 5 and 40 µM ibuprofen; 200–400, ‘high ibuprofen treatments’ with 200 and 400
µM ibuprofen; A5–40, ‘low ibuprofen treatments’ with supplemental 1 mM acetate; A200–400, ‘high ibuprofen
treatments’ with supplemental 1 mM acetate. Filled and open circles, DNA and RNA (cDNA) level, respectively.
Figure S6: Heat map of LEfSe identified top 50 most differentially abundant taxa based on 16S rRNA gene (A) and
16S rRNA (cDNA; B) amplicon analysis after the third and fifth refeeding (Figure 1). OTUs are sorted according to
the difference in their mean read counts in ibuprofen amended and unamended samples. OTUs with a linear
discriminant analysis score of ≥4 and their phylogenetic affiliation are shown. The color code reflects median,
as well as upper and lower quantiles of read counts normalized to the total number of reads per OTU from all
samples. Sample code: A, amended with 1 mM acetate and ibuprofen per feeding; 0, 5, 40, 200, and 400 indicate
supplemental ibuprofen concentrations in µM given per feeding; 0′, 3′, and 5′ correspond to samples obtained at
the start of the incubation, and after the third and fifth refeeding, respectively. Sampling times for unamended
controls were according to those of the 400 µM ibuprofen treatment. *, Samples with significant differential relative
abundance compared to the start of the incubation based on DESeq2 (adj p < 0.1). Figure S7: Phylogenetic tree
reconstructed with the neighbour-joining method based on 16S rRNA gene sequences of strain CN1 and other
Novosphingobium species (panel A) and strain MAH1 and other Pseudomonas species (panel B), showing their
position among phylogenetic neighbours. Aquicella siphonis strain SGT-108 was used as an outgroup. Bootstrap
values (based on 1000 replications) above 70% are shown at branch nodes. Figure S8: Hypothetical ibuprofen
degradation pathways in oxic hyporheic zone sediments based on the transformation products identified in the
current study and previous studies as reported in [48]. Table S1: Sequences and annealing temperature of primer
sets targeting representative ibuprofen-responsive taxa (400 µM ibuprofen treatment; Figures 2 and 3, Table S2).
The primers were used to amplify the 16S rRNA gene and corresponding 16S rRNA transcripts (cDNA). Table S2:
Classification of bacterial OTUs enriched by ibuprofen relative to unamended controls sampled at the same time
point, and closest cultured relatives of OTU representative 16S rRNA gene sequences. Significant (p-adj < 0.05)
Log2-fold change >0 are reported as determined by Deseq2. IBU40 and IBU400, ibuprofen amendment with 40
and 400 µM ibuprofen, respectively. IBA40 and IBA400, ibuprofen amendment with 40 and 400 µM ibuprofen,
respectively, together with 1 mM acetate. Table S3: Relative abundance of bacterial OTUs from the original
microbial community enriched by 40 and 400 µM ibuprofen treatments at DNA and RNA levels under oxic
conditions after incubation. 0, represents unamended samples and 40 and 400 correspond to samples amended
with 40 and 400 µM ibuprofen, respectively. 0′, 3′, and 5′ correspond to samples obtained at the start of the
incubation, and after the third and fifth refeeding, respectively. Data represents the mean of triplicate samples in
% of total rarified reads (uniform sequencing depth of 10,767 per sample) ± standard error of mean (SEM).
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